• Tofacitinib (CP-690550) Workflows for Immune Modulation Rese

  2026-05-13

  Tofacitinib (CP-690550) enables precise inhibition of JAK/STAT signaling, uniquely reversing GM-CSF-driven inflammation and mitochondrial dysfunction in immune cell models. This article translates cutting-edge findings into actionable protocols, troubleshooting guidance, and comparative advantages for advanced immune modulation research.

• Methotrexate as a Folate Antagonist: Applied Research Workfl

  2026-05-13

  Methotrexate’s versatility as a folate antagonist empowers robust research into immunosuppression, apoptosis, and anti-inflammatory mechanisms. This guide delivers actionable protocols, advanced troubleshooting, and comparative insights for maximizing reproducibility with APExBIO’s validated Methotrexate.

• Bright Light Triggers Lasting Anxiety via ipRGC–CeA Circuitr

  2026-05-12

  Wang et al. elucidate how brief acute bright light exposure in mice produces a sustained anxiogenic effect, mediated by melanopsin-expressing retinal ganglion cells (ipRGCs) projecting to the central amygdala. This research advances understanding of non-image forming visual circuits in mood regulation and provides chemogenetic circuit-mapping strategies for neuroscience.

• SB 202190: Applied Protocols for p38 MAP Kinase Inhibition

  2026-05-12

  SB 202190, a highly selective p38 MAP kinase inhibitor, enables precise dissection of MAPK signaling in inflammation and cancer models. This article translates new organoid-based research and best practices into actionable workflows, troubleshooting, and advanced use-cases for researchers.

• Dutasteride: Mechanistic Leverage for Translational Prostate

  2026-05-11

  Explore the dual 5-alpha-reductase inhibition of Dutasteride and its transformative impact on prostate cancer and BPH research. This thought-leadership article integrates mechanistic insights with translational strategy, providing protocol guidance, competitive differentiation, and a vision for future research innovation. APExBIO's Dutasteride stands out as a robust tool, advancing both experimental reliability and the scope of androgen pathway modulation.

• KX2-391 dihydrochloride: Dual Mechanism Workflows in Cancer

  2026-05-11

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) offers unprecedented versatility as a dual Src kinase and tubulin inhibitor, enabling precision targeting of oncogenic and viral pathways. This article distills new mechanistic insights and validated workflows to empower bench researchers in oncology, antiviral, and neurotoxin studies.

• Ruxolitinib Induces Mitochondrial Dysfunction in ATC via DRP

  2026-05-10

  This study demonstrates that Ruxolitinib (INCB018424) triggers apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) by suppressing DRP1-mediated mitochondrial fission through JAK1/2-STAT3 pathway inhibition. The findings reveal a previously unrecognized link between JAK/STAT signaling and mitochondrial dynamics in aggressive thyroid cancer, suggesting new therapeutic avenues.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) for High-Precision mRNA Deli

  2026-05-09

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables direct, quantitative tracking of both mRNA uptake and translation efficiency in living cells, streamlining advanced gene delivery assays. Its dual fluorescence and immune-evasive modifications make it the gold standard for nanoparticle validation and gene function studies where reliable readouts are essential.

• FBXO22 Ligand Discovery Expands Targeted Protein Degradation

  2026-05-08

  This study introduces novel chemical probes for the E3 ligase FBXO22, including the degrader AHPC(Me)-C6-NH2 and the recruitment ligand 2-pyridinecarboxaldehyde (2-PCA). These advances broaden the ligand repertoire for targeted protein degradation (TPD), offering new strategies to address current limitations in E3 ligase targeting and proteostasis research.

• NSC-23766: Rac GTPase Inhibitor for Advanced Cell Signaling

  2026-05-08

  NSC-23766 empowers researchers to dissect Rac1-driven signaling with precision, supporting reproducible workflows in cancer, apoptosis, and barrier function studies. Explore protocol enhancements, troubleshooting tips, and novel applications informed by the latest insights on Rac1 modulation and insulin-independent glucose uptake.

• SB 202190: Selective p38 MAP Kinase Inhibitor Evidence & Pro

  2026-05-07

  SB 202190 is a potent, ATP-competitive p38 MAP kinase inhibitor, widely used in inflammation research and cancer therapeutics. Its high selectivity for p38α/β enables precise dissection of MAPK signaling with validated protocols and robust benchmarks.

• AZD2461: Data-Driven PARP Inhibition for Reliable Lab Workfl

  2026-05-07

  This scenario-driven guide addresses core challenges in breast cancer research, focusing on cell viability, DNA repair, and drug resistance. Leveraging the validated performance of AZD2461 (SKU A4164), the article offers evidence-based solutions and protocol guidance for reproducible results in demanding cell-based assays.

• Advancing mRNA Delivery: Dual-Reporter Tools for Translation

  2026-05-06

  This thought-leadership article analyzes the mechanistic and strategic value of dual-fluorescent, immune-evasive reporter mRNA platforms—focusing on EZ Cap™ Cy5 EGFP mRNA (5-moUTP)—for accelerating translational gene delivery research. Integrating recent literature on lipid nanoparticle targeting and immune modulation with state-of-the-art workflow guidance, the article offers evidence-based recommendations for optimizing mRNA delivery, translation efficiency, and quantitative analytics. It also contextualizes APExBIO’s offering versus competitive tools, bridges to emerging clinical needs, and outlines future pathways for precision medicine.

• Melittin as a Bioactive Peptide Tool in Signal Transduction

  2026-05-06

  Melittin, a robust bioactive peptide, empowers researchers to dissect GPCR-mediated pathways, apoptosis, and cancer cell signaling with high selectivity and solubility. This article details actionable workflows, troubleshooting tactics, and evidence-backed innovations, positioning Melittin as an indispensable reagent for advanced cell biology research.

• Cyanine 3 Tyramide: Fluorescent Dye Powering Biomedical Rese

  2026-05-05

  Cyanine 3 Tyramide delivers exceptional signal amplification, transforming workflows in immunohistochemistry, in situ hybridization, and flow cytometry. Drawing on recent neuroscience research and hands-on protocol optimization, this guide offers actionable insights for researchers seeking robust, reproducible fluorescence labeling.

14768 records 1/985 page Next 12345 下5页 Last page